Showing results (1101-1110 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|March 31, 2015
Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesJacoline C Bouvy, Marie L De Bruin, Marc A KoopmanschapDrug Safety|February 26, 2015
User-driven development of a web-based tool for patient reporting of drug-related harmMonica Plöen, Magnus Wallberg, Sten OlssonDrug Safety|April 27, 2023
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical TrialsFariba Ahmadizar, Nicoletta Luxi, Monika Raethke, et al.Drug Safety|April 19, 2023
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR TrialLisa M Kalisch Ellett, Gerel Dorj, Andre Q Andrade, et al.Drug Safety|April 23, 2023
Quality of MedDRA® Coding in a Sample of COVID-19 Vaccine Medication Error DataKatarina Kralova, Carol-Ann Wilson, Nicolas Richebourg, et al.Drug Safety|July 11, 2020
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine FibroidsSarah Kang, Allen Brinker, S Christopher Jones, et al.Drug Safety|June 29, 2020
Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on HepatotoxicityJames H Lewis, Paul H Cottu, Martin Lehr, et al.Drug Safety|July 25, 2020
Pharmaceutical Benefit-Risk Perception and Age Differences in the USA and GermanyDominic H P Balog-Way, Darrick Evensen, Ragnar E LöfstedtDrug Safety|March 5, 2015
Initiatives to identify and mitigate medication errors in EnglandDavid Cousins, David Gerrett, Natalie Richards, et al.Drug Safety|March 27, 2015
Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in BelarusSvetlana Setkina, Marina Dotsenko, Sviatlana Bondar, et al.Pageof 309